Uterine leiomyomas (ULM) grow under high oxidative stress due to a hypoxic microenvironment and defects in redox metabolism. AKT is one major pathway activated by reactive oxygen species (ROS) that maintains ULM growth and survival. We previously reported that AKT inactivated by AKT inhibitors can significantly induce cellular senescence in ULM cells. Since some miRNAs are induced by AKT inhibitors in an ROS-dependent manner, we proposed that these miRNAs may modulate AKT function and cellular senescence in ULM. We therefore established ex vivo models of a three-dimensional ULM spheroid culture system to study the role of miRNAs in cellular senescence. Four miRNAs, miR-29b, miR-181a, miR-182, and miR-200c, were found to induce cellular senescence in primary ULM and myometrium spheroid cultures when stably overexpressed. miR181a and miR-182 were found to repress AKT3 and CCND2, respectively. Correspondingly, RNAi of AKT3 or CCND2 also induced cellular senescence and G0/G1 arrest. Thus, miR-181a and miR-182 may drive cellular senescence in ULM by repressing AKT3 and CCND2 activity, respectively. We further demonstrated that senescent ULM cells can be effectively removed by BH3 mimetic ABT263, which provides a new therapeutic venue for the treatment of ULM. Our findings suggest that miRNAs are potent modulators in regulating the ROS-AKT-cell cycle axis in uterine leiomyoma. 
Introduction
Uterine leiomyomas (ULM) are smooth-muscle tumors of the myometrium that occur in 77% of women in the USA [1] . ULM are generally slow-growing tumors driven by sex steroid hormones and growth factors. Due to poor vasculature and excessive collagen production, ULM grow in an unfavorable hypoxic microenvironment [2, 3] . Such hypoxic conditions increase levels of reactive oxygen species (ROS) [4, 5] .Recently, we demonstrated that ULM has dysfunctional MnSOD activity leading to accumulation of ROS which can activate AKT signaling [6] . AKT may play a major role in maintaining ULM growth and survival under oxidative stress [6, 7] . Previous studies have shown that inactivation of AKT by the AKT inhibitor MK2206 in ULM cells enhances ROS production and induces cellular senescence at low doses [8] or cell death at high doses [7] . Therefore, a balance of ROS levels and AKT activity is vital for ULM growth and survival. The underlying cellular and molecular mechanisms remain to be fully characterized and deserve further investigation. Deciphering these molecular mechanisms can be valuable for the development of targeted therapies.
miRNAs, which are small non-coding RNAs, are early response molecules to cellular stresses. It has been shown that a subset of miRNAs can be induced by oxidative stress [9, 10] . Induced miRNAs react to oxidative stress through modulating the expression of their target genes at the levels of transcription and translation. These target genes may redirect the cells from proliferation to cellular arrest to prevent further cellular damage [11] . Since hypoxia and increased ROS production in cells can elicit an adaptive response that involves activation of the AKT pathway [6] and induction of miRNAs that serve as downstream effectors and upstream regulators of AKT activity [12] , identification of the key miRNAs that are induced under these conditions will help elucidate the functional relationship between miRNAs and stress response in ULM. ULM are under increased oxidative stress, and AKT serves as a major pathway for ULM cell growth and survival. Inactivation of AKT by AKT inhibitors can induce cellular senescence. Many miRNAs can be induced by ROS, and we speculated that these miRNAs may modulate AKT function and cellular senescence in ULM. Review of the literature and our previous studies demonstrated that a subset of miRNAs were dysregulated with oxidative exposure. In this study, we studied the miRNAs induced by ROS and the AKT inhibitor. We demonstrated that miR-181a and miR-182 repress ATK3 and cyclin D2 and function to promote senescence.
Materials and methods

Collection of tissue samples and culture of primary cells
Fresh surgical specimens of uterine leiomyoma (ULM) and myometrium (MM) were obtained from consented premenopausal women undergoing hysterectomy at the Northwestern University Prentice Women's Hospital (Chicago, IL, USA), and the protocol for acquisition of specimens was approved by Northwestern University's Institutional Review Board (IRB). The study tissue pool includes 28 cases with a mean age of 44.9 years (range of 37-55 years) and tumor size of 9.2 ± 2.7 cm. Among them, 46.4% (13/28) were African American, 32.1% (9/28) were Caucasian, and 21.4% (6/28) were of other ethnic groups (Supplementary Table 1 ). Subjects included in the study were not taking hormonal contraceptives nor had hormonal treatment for at least 3 months. Tissue was minced into small pieces and digested with collagenase A and DNase (Sigma-Aldrich) for 5 h on a 37°C tissue shaker. The digested material was filtered to obtain a single-cell suspension. The primary cells were cultured in smooth muscle cell basal medium (SmBM; Clonetics, Lonza Group, Switzerland) at 37°C and 5% CO 2 atmosphere no longer than 10 days.
Three-dimensional leiomyoma spheroid cultures
Primary cells were suspended and seeded in 6-well (coated with 1.5% agarose gel) or 96-well ultra low attachment culture plates (Corning). Cells were cultured with mesenchymal stem cell medium (Lonza, cat no. 190632 or cat no. PT-3001), and incubated at 37°C in the humidified incubator with 5% CO 2 for at least 48 h for formation of spheroids. The spheroids were evaluated with the inverted microscope. Spheroid cultures were maintained for up to 5-7 days and further processed for β-galactosidase staining.
Treatment of cells
Primary ULM and MM cells or spheroids were treated with 0 μM (DMSO), 2 μM, and 5 μM MK-2206 (SelleckChem) for 24 h, with 0 μM (3DW), 100 μM, and 200 μM paraquat (PQ) (Sigma-Aldrich) in serum-free medium for 6 h, with 0 μM (DMSO) and 5 μM ABT263 and ABT199 (provided by AbbVie Inc., North Chicago, IL) for 0, 2, 4, and 6 days.
siRNA transfection
ULM and MM cells in monolayers were transfected with ONTARGETplus SMART pool siRNAs (GE Dharmacon) for CCND2 and AKT3 using Lipofectamine RNAiMAX (Thermo Fisher Scientific) according to the manufacturer's instructions. A non-targeting siRNA (siCTR; GE Dharmacon) was used in parallel as a control for each assay. After 48 h, cells were harvested or fixed for further analysis. For spheroids, cells were transfected with test and control siRNAs in monolayer cultures first and then transferred to threedimensional culture for spheroid formation.
Quantitative real-time RT-PCR
Total RNA was isolated using the mirVana™ RNA Isolation Kit (Ambion, Austin, TX). The detailed method was described previously [13] . Then, cDNA was prepared by a Mir-X™ miRNA First Strand Synthesis Kit (Clontech, Mountain View, CA). The entire sequence of mature miRNAwas used as miRNA-specific, 5′ primer (Supplementary Table 2 ). The 3′ primer for qPCR is the mRQ 3' primer supplied with the kit. For real-time PCR, cDNA was synthesized by PowerUp™ SYBR® Green Master Mix (Life Technologies) using the Applied Biosystems® StepOnePlus™ Real-Time PCR Systems with sequencespecific miRNA primers. Relative mRNA levels were calculated using the 2 −ΔΔCt method. The miRNA levels were normalized to U6. Results were obtained from at least three independent experiments performed in triplicate.
Western blotting
Cultured cells were harvested and lysed on ice in RIPA lysis and extraction buffer with protease and phosphatase inhibitors (Thermo Fisher Scientific). The concentration was determined by using BCA Protein Assay kit (Thermo Fisher Scientific). Total protein (30 μg) was separated by SDS-PAGE and electro-transferred onto polyvinylidene fluoride membrane (Invitrogen, Grand Island, NY). The membranes were blocked with 5% BSA in TBST, then incubated with primary antibodies overnight at 4°C. The specific horseradish peroxidaseconjugated goat anti-rabbit or goat anti-mouse secondary antibody (Bio-Rad, Hercules, CA) was used to blot the target proteins (Supplementary Table 3) , and the secondary antibody was detected by an enhanced chemiluminescence ECL detection kit (Bio-Rad, Hercules, CA).
β-Galactosidase staining
Senescence-associated β-Gal staining was done as previously described [8] . In brief, monolayer cells were seeded in 6-well plates overnight. After appropriate treatments (siRNA, lentiviral transfection, MK2206, PQ), the cells were fixed with 2% formaldehyde and 0.2% glutaraldehyde in PBS at room temperature for 15 min. After washing with PBS, cells were stained with staining solution containing 1 mg/mL X-gal and incubated in a CO 2 -free incubator at 37°C for 16 h. Blue cells were counted under the microscope and statistically analyzed. Five randomly selected fields were captured, and the percentage of cells that were positive for β-galactosidase was calculated and averaged. For spheroids, cells were transfected with miRNA lentivirus for 48 h and then the medium was changed; after 5 days, all the spheroids were collected in tubes, then fixed with formaldehyde and 0.2% glutaraldehyde in PBS at room temperature for 15 min. After washing with PBS, cells were stained with staining solution containing 1 mg/mL X-gal and incubated in a CO 2 -free incubator at 37°C for 3 h. The reactions were terminated when the cells were stained blue-green. Spheroids were resuspended in 100 μL 70% glycerinum, and seeded onto glass slide, then visualized under an inverted bright-field microscope.
Lentiviral packaging and transduction
Lentiviral pre-miRNA constructs and viral particles were prepared as previously described [14] . Briefly, lentiviral vectors with and without pre-miRNAs were cotransfected with psPAX2 and pMD2G vectors into HEK293T cells.
Supernatants were collected at 24 h and 48 h after transfection and stored in − 80°C. For transduction, 5 × 10 4 cells were plated in each well of the six-well plates along with 2 mL of medium without antibiotics. After 48 h of incubation, the medium was removed and replaced with 1 mL medium containing lentivirus. Forty-eight hours later, fresh medium containing 1 μg/mL puromycin was added to each well.
Analysis of cell cycle by flow cytometry
Cells were serum-starved for 24 h before treatment. Control and treated cells were harvested using 0.25% Trypsin and washed once with cold PBS. The pellets were resuspended in ice-cold 70% ethanol and stored at − 20°C. Samples were incubated with 20 mg/mL propidium iodide 0.1% Triton X-100 staining solution with 0.1 mg/mL RNase A. Cell cycle distribution was determined using the BD Biosciences FACSCanto II Analyzer. At least 20,000 cells were collected. For these studies, all experiments were repeated three times.
WST-1 viability assay
Primary ULM and MM cells were cultured in 96-well plates. At the end of treatments, WST-1 (BioVision) was added to each well (1:10 dilution) for 4 h at 37°C, and absorbance was read at 420 nm with the reference wavelength set at 650 nm. Data were analyzed following the manufacturer's manual.
3′-UTR of AKT3 vector construction and luciferase reporter assay
The 3′-untranslated region (UTR) of human AKT3 containing two putative miR-181a binding sites was amplified from human genomic DNA and cloned into psiCHECK2 vector (Promega, Madison, WI, USA) using the XhoI and NotI sites. The psiCHECK2-AKT3-mut construct (replacing the nucleotide at the miR-181a Bseed^sequence-binding sites [15] , Supplementary Table 2) was mutated by using the QuikChange XL Mutagenesis Kit (Stratagene, La Jolla, CA) [16] . For the luciferase assay, HEK293T cells were seeded at 1 × 10 4 cells per well in a 96-well plate. Twenty-four hours later, cells were transfected with 100 ng of psiCHECK2 control, psiCHECK2-AKT3-WT, or psiCHECK2-AKT3-mut plasmid, and for each well, 20 nM of miR-181a mimic or miR-NC was cotransfected with the reporter construct as indicated. Twenty-four hours later, luciferase activity was measured using the Dual-Luciferase Reporter System (Promega).
Statistical analysis
Results are presented as mean ± SEM. GraphPad Prism was used for statistical analysis. Student's t-test (two groups) and ANOVA (multiple groups) were used to determine significance. P < 0.05 was considered statistically significant, and levels of significance were presented at *P < 0.05, **P < 0.01, and ***P < 0.001, respectively. Data from each patient were considered as an independent experiment.
Results
Oxidative stress-induced miRNA expression in ULM and matched myometrium Among those miRNAs regulated by oxidative stress (45 miRNAs were upregulated and 24 downregulated (Supplementary Table 4 )), we chose 11 miRNAs that were also highly dysregulated in ULM [17, 18] , including let-7c, miR-22, miR-29b, miR-96, miR-99a, miR-145, miR-155, miR181a, miR-182, miR-195, miR-200a, and miR-200c. In order to determine which miRNAs were induced by both ROS and AKT inhibitors, primary ULM cells and MM cells were treated with the superoxide anion generator, paraquat (PQ), as well as the AKT inhibitor, MK2206. Among three independent cases, miRNAs (miR-29b, miR-181a, miR-182, and miR200c) were repeatedly induced by both PQ and MK2206 in primary ULM cells which was dose dependent (Fig. 1b, d) . Similar results were observed in some but not all MM cells (Fig. 1a, c) . The findings show that these specific miRNAs are inducible under oxidative stress or AKT inactivation.
Establish stable miRNA expression in primary ULM and MM cells
To evaluate the functional role of ROS/MK2206-induced miRNAs in ULM and MM, stable miRNA expression was established using lentiviral constructs which contain premiRNAs of miR-29b, miR-181a, miR-182, or miR-200c, by the method described previously [14] . The efficacy of lentiviral infection was illustrated by bright and diffuse green fluorescence in over 80% of culture cells (Supplementary Figure 1) . To confirm miRNA overexpression in primary culture ULM . e Relative expression of the selected miRNAs between primary myometrium (MM) and leiomyoma (ULM) are illustrated. Small T bar stands for standard error. *P < 0.05, **P < 0.01, ***P < 0.001 and MM cells, miRNA expression was examined by miRNA RT-PCR (Fig. 2a) . Of note, the fold increase in miRNA expression varied in different miRNA constructs, suggestive of different efficacies in miRNA maturation processes. To evaluate the miRNA function in primary ULM and myometrial cells, we overexpressed miRNAs in the spheroid cultures. After miRNA overexpression was confirmed, the primary cells in monolayers were cultured as spheroids. Upon spheroid formation after 3-5 days, stable lentiviral infection was confirmed by the presence of green fluorescence (Fig. 2b) .
Overexpression of stress-induced miRNAs resulted in cellular senescence in ULM and MM To determine whether the selected miRNAs induced senescence, ULM and MM cells overexpressing the miRNAs and cultured as spheroids were fixed and stained for SA-β-galactosidase. As illustrated in Fig. 3a , b, 3D spheroid MM and ULM showed a global senescence pattern and a significant increase in cellular senescence was observed in both ULM and MM spheroids with overexpressing miR-29b, miR-181a, miR-182, and miR-200c compared to vector controls. The level of senescence in matched MM was relatively lower than in ULM (Fig. 3a, b) . Of note, miR-181a and miR-182 overexpression resulted in an intense and diffusive pattern of β-galactosidase staining in ULM. miR-29b overexpression could also increase senescence but not miR-200c (Fig. 3a, b) . These data were confirmed in three cases (Supplementary Figure 2) .The monolayer of ULM and MM cells with miRNA overexpression was also examined by β-galactosidase staining and was found to be positive (Supplementary Figure 3) . In the 2D cultures of primary MM and LM cells, senescence was evaluated in individual cells which showed that miR-181a and miR-182 overexpression resulted in a nearly 1.5-fold increase in cellular senescence as detected by β-Gal staining (Supplementary Figure 3B, C) . Senescent cells are usually arrested in the G0 phase of the cell cycle. Cell cycle analysis showed that about 50% of cells were in the G0/G1 phase in primary culture (day 5-7) of both myometrial and leiomyoma cells (Fig. 3c, d ). In contrast, the same primary culture of ULM and MM cells with overexpression of miR-181a and miR-182 had significantly high percentages of G0/G1 cells (69.43% in MM and 79.9% in LM with overexpression of miR-181a; 86.96% in MM and 76.84% in LM with overexpression of miR-182; P < 0.05). These findings further support that miR-181a and miR-182 overexpression can drive smooth muscle cells into cellular arrest or senescence.
miR-181a represses AKT3 in fibroids
Findings of miR-181a and miR-182 overexpression driving cellular senescence prompted us to investigate the underlying mechanism. We speculated that some miR-181a target genes may play an important role in protecting ULM cells from ROSmediated DNA damage and drive ULM cell into senescence. Among the target genes predicted to be targeted by miR-181a by PicTar and TargetScan, AKT3 was one of the top predicted target genes. AKT activity is critical for ULM cell survival and proliferation. AKT3 was moderately expressed in both MM and ULM, but varied from case to case (Fig. 4a) . Transient transfection of miR-181a in MM and ULM cells consistently reduced AKT3 expression (Fig. 4a) . miR-181a-mediated repression of phosphorylated AKT was also observed in MM and ULM cells (Fig. 4b) . Silicon analysis revealed that there are two highly reserved miR-181a-5p binding sites at the 3′-UTR of AKT3 (Fig. 4c) . To confirm that miR-181a-5p specifically repress AKT3 expression, two miR-181a-5p binding sites at the 3′-UTR of AKT3 were mutated by CRISPR/CAS9 techniques at the 3rd and 6th nucleotides complementary to miR181a-5p seed sequence (Fig. 4c) . Luciferase activity was blocked in wild-type 3′-UTR, but not in mutant 3′-UTR, by miR-181a-5p in the HEK293 cell line (Fig. 4d) . Consistently, miR-181a overexpression can reduce the luciferase activity when transfection of luciferase with AKT3 3′-UTR in myometrial cells (Fig. 4e) . These results indicate that miR181a-5p can specifically inhibit AKT3 expression.
While miR-182 has several direct and indirect target genes involved in DNA repair, several cell cycle regulators are also regulated by miR-182, including p21 and CCND2 [19] . When miR-182 was overexpressed in MM and ULM cells, upregulation of p21 was observed in some but not all cases (data not shown). In contrast, miR-182 overexpression consistently represses CCND2 expression in all MM and LM cells tested (Fig. 4f) . Taken together, ROS-induced miR-181a and miR-182 result in significant downregulation of AKT3 and CCND2.
Silencing of AKT3 and CCND2 expression drives ULM cell into cellular senescence and cycle arrest
To further evaluate the functional role of AKT3 in cultured ULM and MM cells, AKT3 expression was silenced by siRNA. Upon AKT3 silencing (Fig. 5a) , levels of β-galactosidase increased, demonstrating an increase in senescent cells in ULM and MM spheroids (Fig. 5c) . Moreover, AKT3 silencing increased the percentage of cells in G0/G1 of the cell cycle (Fig. 5e) . Similarly, silencing CCND2 (Fig.  5b) showed increases in β-galactosidase staining and the number of cells in the G0/G1 phase (Fig. 5d, f) . These data suggest that, in particular, miR181a and miR-182 serve as regulators of AKT3 and CCND2 that eventually drive cells into permanent arrest/senescence.
BH3 mimetics are effective in reducing viability of senescent cells in ULM
Recent studies showed that a novel class of therapeutic molecules, BH3-mimetics, can reduce or clear senescent cells Fig. 4 Analysis of miR181a repression of AKT3 and miR182 repression of CCND2 in myometrial (MM) and leiomyoma (ULM) cells. a Western blot analysis of AKT3 expression in MM and ULM cells (n = 3) with (+) and without (−) miR-181a overexpression. Total AKT, GAPDH, and β-actin were used as loading controls. b Western blot analysis of phosphorylated AKT1/2/3, AKT3, total AKT, and actin expression in MM and ULM cells (n = 3) with (+) and without (−) miR-181a overexpression. c Two miR-181a binding site sequences at the 3′-UTR of AKT3 with introduced mutant nucleotides (in red) were prepared. d Luciferase activity in the AKT3 3′-UTR sequence without (left, UTR-WT) and with (right, UTR-mut) mutant binding sites of miR-181a was examined when treated with miRNA mimic control (miR-NC) and miR-181a in the HEK293T cell line. e Luciferase activity in the AKT3 3′-UTR sequence with binding sites of miR-181a was examined when treated with miRNA mimic control (miR-NC) and miR-181a in myometrial cells. f Western blot analysis of CCND2 expression in MM and ULM cells (n = 3) with and without miR-182 overexpression. β-Actin was used as loading control. β-Actin was used as loading control. Small T bar stands for standard error. *P < 0.05; **P < 0.01 through targeting the Bcl-2 family [20] . ABT263 is one of such compounds developed by AbbVie. To evaluate whether ABT263 can be used in reduction or removal of senescent cells in ULM, we examined the level of cellular senescence and cell viability in ULM cells. miR-181a and miR-182 were overexpressed by transduction of miRNA lentivirus in fresh collected primary ULM cells. Cells were transferred to spheroid culture, and miRNA overexpression was evaluated by a fluorescent scope (Fig. 6a, b) . Then, ULM spheroids with miRNA overexpression were treated with control (DMSO) and senolytic compound (ABT263). After ABT263 treatment for 4 days, there was a significant increase in cell death under light microscope, demonstrating a ring of disassociated cell debris around spheroids (Fig. 6a, b) . These spheroids were then fixed briefly and further examined by β-galactosidase stain. Notably, spheroids treated by ABT263 showed minimal β-galactosidase-positive cells in comparison to DMSO control (Fig. 6a, b) . These findings indicate that ABT263 can effectively kill senescence ULM cells induced by miR-181a and miR-182. To further confirm the findings, the viability of ULM cells with miRNA overexpression was examined by liquid base assay. As shown in Fig. 6c, d , significantly reduced cell viability could only be seen in ULM cells with miR-181a or miR-182 overexpression when treated by ABT263. The findings suggest that highly senescent ULM cells can be effectively removed by senolytic therapies such as ABT263.
Discussion
Leiomyomas require pro-survival mechanisms to adapt to an unfavorable hypoxic microenvironment. Emerging evidence points to AKT as a major survival pathway in ULM [6, 7] . Activation of AKT signaling in ULM is in part caused by oxidative stress due to hypoxia and defects of ROS metabolism [6] . Inhibiting the AKT pathway results in a dynamic and transient regulation of specific pathways that ultimately navigate cells into various downstream fates, including decreased proliferation and increased cellular senescence. Direct inactivation of AKT by AKT inhibitors (MK2206) in ULM resulted in significant cellular senescence in vitro [8] . The mechanisms of AKT-mediated cellular senescence are unclear in ULM. Previous studies showed that AKT can either induce or prevent senescence depending on the cellular context. In cells with RAS mutations, activation of AKT can significantly suppress RAS-induced senescence and promote malignant tumor cell growth [21] . In ULM and other cell types, increase in ROS exposure can trigger senescence in vitro [8] , but elevated oxidative exposure also activates AKT signaling through depleting PTEN functions [6] . It has been reported that in glioblastoma cells with PTEN mutations, AKT may directly drive cellular senescence [22] . These findings suggest that AKT may act differently during senescence depending on cell types and functional status. Our findings indicate that miRNAs are important members of the ROS-AKT axis during cellular senescence.
miRNAs are important regulators of cellular response to ROS and oxidative DNA damage. A subset of miRNAs can be induced by ROS exposure [8, 23] . ROS-induced miRNAs play a major role in protecting cells from DNA damage [24] and mitochondrial dysfunction [25] . Since MK2206-induced cellular senescence occurs in a ROS-dependent manner [8] , we proposed that some ROS-induced miRNAs may modulate AKT activity and cell cycle genes. We found that a subset of miRNAs can be induced by both ROS and AKT inhibitor MK2206 in primary ULM and matched myometrial cells. Overexpression of these miRNAs (miR-29b, miR-181a, miR-182, and, miR-200c) significantly increased cellular senescence and cell cycle arrest at G0/G1 in both ULM and myometrial cells (Fig. 3) . Among them, miR-181a and miR-182 overexpression resulted in a strong induction of cellular senescence in all cases of ULM and myometrial cells, observed in both monolayer and spheroid cultures (Fig. 3,  Supplementary Figure 3) . miR-182 targets multiple pathways. It was shown to negatively regulate BRCA1 [14, 26] and positively regulate P21 (CDKN1A) in cells with normal p53 status [27] . In addition, miR-182 can regulate the cell cycle in response to DNA damage [24] . A recent study showed that miR-182 overexpression induced G1-phase arrest via inhibition of AKT/FOXO3a signaling [28] . Interestingly, cyclin D2 (CCND2) is a major cell cycle regulator downstream of AKT. AKT promotes CCND2 activity through its negative regulation of GSK-3β [29] . CCND2 and CDK4/6 form a complex to promote cell proliferation at G1/S transition [30] . The findings of miR-182 repression of CCND2 in ULM in this study (Fig. 4) and other cell types [19] suggest that ROS-induced G1-phase arrest or senescence in ULM is related to downregulation of CCND2 by miR-182. miR-181a is recognized as a senescence-associated miRNA and is modulated by ROS [31] and highly expressed in senescent cells [32, 33] . miRNA expression profiling revealed continuous changes in the expression of miR-181a during the whole senescence process [34] . Importantly, pathway analysis revealed that many miR-181a target genes are related to replicative senescence and cell cycle progression, both G1/S and G2/M cell cycle phase transitions, and telomere maintenance [35] . We found that miR-181a is significantly upregulated in ULM when exposed to ROS. Silicon target gene analysis revealed that several functional genes in the AKT pathway may be directly regulated by miR-181a, including IGF2BP2 and AKT3. IGF2BP2 was recently confirmed to be a miR-181a target [36] . In this study, we demonstrated that AKT3, a AKT subunit overexpressed in ULM, is the target gene of miR-181a. Two conservative binding sites of miR-181a at the 3′-UTR of AKT were identified. Introducing miR-181a overexpression in ULM cells in vitro resulted in AKT3 downregulation. When generating specific mutations of miR-181a binding sites, miR181a repression of AKT3 was lost. Collectively, these findings confirmed that AKT3 is the direct target of miR-181a (Fig. 5) . This, along with its upstream target of IGF2BP2, makes miR181a a potent negative regulator for the AKT pathway. Taken together, ROS-induced miR-181a may promote cellular senescence through its negative regulation of cell cycle and AKT pathway genes.
miR-29b and miR-200c are two stress-responding miRNAs in regulation of cell proliferation and remodeling signaling. These two miRNAs express in low level in primary ULM [17, 18, [37] [38] [39] and can be induced by ROS and AKT inhibitors and also drive ULM cell into senescence. Based on the current study and published data, the selected miRNAs can directly or indirectly regulate many functional genes in the AKT pathway and they are summarized in Fig. 7 . These findings support that in an environment of oxidative stress, miRNAs and activation of AKT and its downstream effectors are intricately connected and balanced in order for leiomyoma cells to grow and survive. If the balance is interrupted, oxidative stress can promote cellular senescence or cell death. Understanding these molecular mechanisms in ULM will help to develop targeted therapies to control ULM growth. One of the challenges for such efforts is that the senescent cells may produce undesignable effects by the acquisition of a senescence-associated secretory phenotype (SASP). SASP may promote non-senescent tumor cell growth [40] . Apparently, clearance of senescent cells is desirable. Recent studies discovered that ABT263, an anti-Bcl-2 family compound, can effectively kill senescent cells [20] . In out pilot test, when treated with ABT263 in senescent ULM cells induced by in vitro passage and miR-182 overexpression, significant cell death of senescent cells was observed (Fig. 6 ). This preliminary results provide a great potential for our future study with a combined senescence and senolytic approach in treating ULM.
In summary, we identified a subset of miRNAs which were inducible by both oxidative stress and AKT inactivation. Overexpression of these miRNAs resulted in significant cellular senescence in ULM in vitro and also in ex vivo system. Our finding suggests that under oxidative stress, an interaction of the stress-induced miRNAs and AKT activation are the major cellular and molecular events for cell survival and growth.
